Multimedia

Dr Allegretti reviews her presentation at the Advances in Inflammatory Bowel Disease regional meeting on how to position sphingostine 1-phosphate receptor modulators to optimize patient care in IBD.

Dr Moss recaps his presentation on the safety and efficacy of Janus kinase inhibitors in the treatment of inflammatory bowel disease from the AIBD regional meeting.

Dr Moss, from Boston University, reviewed 3 key steps in optimizing care for patients with luminal Crohn disease during his presentation at the Advances in Regional Bowel Diseases regional meeting.

Dr Ha, from Mayo Clinic-Arizona, review the steps to properly diagnose stricturing Crohn disease and considerations in choosing and positioning therapies.

In this episode of IBD Drive Time, Drs Millie Long and Raymond Cross talk to Dr Parambir Dulai about abstracts from the ECCO ’23 Congress on the role of biomarkers in the clinical care and research for inflammatory bowel disease.

Dr Hyman explains how surgery can be a highly efficacious option for first-line therapy of penetrating Crohn disease.

Dr Salwen-Deremer discusses some findings of her research into insomnia and sleep disturbance in inflammatory bowel disease, and how cognitive behavioral therapy can help.

Dr Kappelman reviews the results of the COMBINE trial, in which the efficacy of combined therapy using antitumor necrosis factor therapies with low-dose methotrexate was compared to anti-TNF monotherapy in pediatric patients with inflammatory...

Dr Rubin discusses his address from Digestive Disease Week 2023 in which he looks to the future of inflammatory disease therapy and advances in the field that include combination therapy, head-to-head drug trials, new therapies and more that...

Dr Melmed, from Cedars-Sinai Medical Center in Los Angeles, reviewed how to implement successful, practical quality improvements to the practice of gastroenterology to optimize outcomes among patients with inflammatory bowel disease.